Injectable PrEP Could Be Approved in 2022 (Cabotegravir)
2246
Bi-monthly injections of cabotegravir may soon be available as new pre-exposure prophylaxis (PrEP) HIV prevention option.
2246
Bi-monthly injections of cabotegravir may soon be available as new pre-exposure prophylaxis (PrEP) HIV prevention option.